COMMUNIQUÉS West-GlobeNewswire

KFSHRC Detects 276 Fetal Genetic Disorders Through Prenatal Care Saving SAR 360 Million Annually

10/02/2025 - 14:09

RIYADH, Saudi Arabia, Feb. 10, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is enhancing prenatal care through innovation and precision medicine. By testing more than 300 genes [...]

Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis

10/02/2025 - 14:30

February 10, 2025 Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis Underscores unmet need for a therapeutic alternative with the potential to delay or prevent surgical removal [...]

Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy

10/02/2025 - 14:30

Company highlights key milestones achieved in 2024, growing revenues and progress towards U.S. expansion in 2025 NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “ [...]

Oncocyte Prices $29.1 Million Equity Offering

10/02/2025 - 14:30

Proceeds Expected to Fund Transplant Assay Through FDA IVD Clearance and Commercial Launch Strategic Partner Bio-Rad Invests, Boosts Support for Trial and Commercialization IRVINE, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE [...]

Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial

10/02/2025 - 14:30

No Safety Concerns Identified by DSMC in the ORCA-OL Long-Term Exposure Trial Achieve Reiterates Planned Cytisinicline NDA Submission in Q2 2025 SEATTLE and VANCOUVER, British Columbia, Feb. 10, 2025 (GLOBE NEWSWIRE [...]

BioCryst to Present New ORLADEYO® (berotralstat) Results from APeX-P Pediatric Trial at 2025 American Academy of Allergy, Asthma & Immunology / World Allergy Organization Joint Congress

10/02/2025 - 14:30

RESEARCH TRIANGLE PARK, N.C., Feb. 10, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present five abstracts featuring new clinical and real-world outcomes [...]

Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis

10/02/2025 - 14:45

Data presented at the 2025 Crohn’s and Colitis Congress PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model without CNS toxicity associated with systemic exposure Company advancing Phase 1a/ [...]

Capricor Therapeutics to Participate in Upcoming Investor Conferences

10/02/2025 - 15:00

SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today [...]

Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition

10/02/2025 - 15:00

HOUSTON, TEXAS, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, announces its [...]

SoldierStrong Joins Forces With Patriot Mobile to Assist Military Veterans in Taking Their Next Steps Forward

10/02/2025 - 15:00

STAMFORD, Conn., Feb. 10, 2025 (GLOBE NEWSWIRE) -- SoldierStrong, a national nonprofit dedicated to providing revolutionary medical technology to U.S. Department of Veterans Affairs medical facilities and individual [...]

Ignite Proteomics Announces Publication of Study Demonstrating Superiority of Protein Activation Analysis in Predicting Breast Cancer Therapy Response

10/02/2025 - 15:15

The new study adds to growing evidence that measuring activated proteins is key to cancer therapy selection. Golden, CO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. ( [...]

Cogent Biosciences Announces Bezuclastinib Poster in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2025 AAAAI Annual Meeting

10/02/2025 - 15:15

WALTHAM, Mass. and BOULDER, Colo., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today [...]

Immix Biopharma Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for NXC-201, sterically-optimized CAR-T for relapsed/refractory AL Amyloidosis

10/02/2025 - 15:35

FDA RMAT designation follows positive proof-of-concept U.S. clinical data from the NXC-201 NEXICART-2 clinical trial in relapsed/refractory AL Amyloidosis RMAT designation potentially streamlines the path to market [...]

Notification of managers' transactions

10/02/2025 - 16:43

ANNOUNCEMENT NO. 288 10 February 2025 Notification of managers’ transactions ChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation no. 596/2014 of transactions related to shares [...]

Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol

10/02/2025 - 17:00

Trading Under New Ticker of “EXOZ” Expected to Begin February 12, 2025 Monrovia, CA, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc., (NASDAQ: IZTC) ("Invizyne"), a leading designer of cell-free, [...]

Press Release: Transparency Notification from Shareholders

10/02/2025 - 17:30

Transparency Notification from Shareholders Ghent, Belgium – 10 February 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the treatment of fluid overload in [...]

Compass Health Announces New Recruitment Initiative Showcasing Career Opportunities and Enhanced Benefits

10/02/2025 - 17:34

EVERETT, Wash., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Compass Health, Northwest Washington’s behavioral healthcare leader, has launched a new recruitment initiative aimed at attracting skilled professionals to its mission- [...]

Revolo to Present at the 2025 AAAAI / WAO Joint Congress

10/02/2025 - 18:00

GAITHERSBURG, Md. and CAMBRIDGE, United Kingdom, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics Limited (“Revolo”) today announced that it will present two posters on its lead candidate, ‘1104, at the 2025 [...]

Comprehensive Healthcare Welcomes Addictionologist to Strengthen Substance Use Disorder Care Delivery

10/02/2025 - 18:15

YAKIMA, Wash., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Comprehensive Healthcare recently welcomed its first-ever board-certified addictionologist, Dr. Gillian Zuckerman, as part of the community behavioral health provider’s [...]